CircCCDC66: Emerging roles and potential clinical values in malignant tumors

Xiaoxiao Wang1, Chao Zhang1, Huangqin Song1

  • 1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.

Frontiers in Oncology
|January 26, 2023
PubMed

Insights

Circular RNAs (circRNAs) are novel oncogenic molecules found in many cancers. CircCCDC66 shows potential as a biomarker for cancer diagnosis, prognosis, and targeted therapies.

Area of Science:

  • Molecular Biology
  • Oncology
  • RNA Biology

Background:

  • Circular RNAs (circRNAs) are non-coding RNAs with a unique closed-loop structure.
  • CircCCDC66 is identified as an oncogenic circRNA upregulated in various cancers.
  • Its role in cancer progression via epigenetic modifications, splicing, transcription, and translation is increasingly recognized.

Purpose of the Study:

  • To review the expression, biological functions, and regulatory mechanisms of circCCDC66 in malignant and non-tumor diseases.
  • To evaluate the clinical value and prognostic significance of circCCDC66.
  • To provide insights for developing new strategies for early cancer diagnosis and targeted treatment.

Main Methods:

  • Literature review and synthesis of existing research on circCCDC66.
  • Analysis of circCCDC66 expression patterns in various cancers.
  • Evaluation of circCCDC66's functional roles and regulatory pathways in tumorigenesis.

Main Results:

  • CircCCDC66 is upregulated in multiple cancers, including thyroid, gastric, and colorectal cancers.
  • It influences cancer progression by modulating epigenetic modifications, splicing, transcription, and translation.
  • CircCCDC66 acts as an oncogene, suppressing or promoting gene expression through direct/indirect pathways.

Conclusions:

  • CircCCDC66 holds significant potential as a biomarker for cancer diagnosis, prognosis assessment, and treatment.
  • Understanding circCCDC66's mechanisms offers new avenues for early cancer detection and targeted therapies.
  • Further research into circCCDC66 is crucial for advancing oncology strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K